American Neurogastroenterology and Motility Society (ANMS) Annual Meeting 2019

American Neurogastroenterology and Motility Society (ANMS) Annual Meeting is organized by American Neurogastro­enterology and Motility Society (ANMS) and will be held from Aug 16 - 18, 2019 at Swissotel Chicago, Chicago, Illinois, United States of America.

Credits:
Clinical Course - Participants can earn up to 8.0 CME and 9.6 for CNE credits.
Scientific Program - Participants can earn up to 8.75 CME and 10.5 for CNE credits.

Description:
Course Overview:
This course will benefit both novice and expert clinicians and clinical investigators through its emphasis on the diagnostic approach and management of gastrointestinal (GI) dysmotility and functional GI disorders. Although the focus of this meeting will be on emerging technologies, the presentations will be valuable to all participants as the pathophysiology of these disease states will be reviewed in parallel to the description of these new approaches.  Presentations will include, but will not be limited to, discussions on all parts of the gastrointestinal tract and will focus on emerging technologies in colonic and anorectal motility disorders, esophageal motility disorders, gastroesophageal reflux disease, nausea and vomiting, gastroparesis, identification and management of irritable bowel syndrome (IBS), brain-gut microbiome axis, diet and food sensitivities.  Additionally, a special section tackling the effect of the opioid epidemic on the GI tract and the role of legalized marijuana on neurogastroenterology and motility diseases will be incorporated as this is becoming an important issue in our field.

Scientific Program Overview:
Will address many cutting-edge research areas which range from basic aspects of neurogastroenterology, translational and clinical aspects of gastrointestinal motility and functional disorders. Topics will include the mechanisms of visceral pain, genetic and epigenetic approaches, role of the gut microbiota, food sensitivities and intolerances, patient reported outcomes and biomedical informatics. Disease areas that will be discussed include including esophageal disorders, functional dyspepsia, gastroparesis, irritable bowel syndrome, chronic constipation, and fecal incontinence.  In addition, participants will learn more about current and novel therapeutic approaches for these conditions including the role of acid-suppressants, prokinetics, probiotics, dietary interventions, visceral analgesics, secretagogues, guanylate cyclase C agonists, and other novel and emerging therapies as well as devices.

Additional details will be posted as soon as they are available.